CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells

Published:2019-12 Issue: Volume:184 Page:110546
ISSN:0927-7765
Container-title:Colloids and Surfaces B: Biointerfaces
language:en
Short-container-title:Colloids and Surfaces B: Biointerfaces

Author:

Guo Zhaoming^ORCID,Liu Ye,Zhou Hao,Zheng Kun,Wang Dong,Jia Mingli,Xu Pengcheng,Ma Kun,Cui Changhao,Wang Li

Funder

National Natural Science Foundation of China

Natural Science Foundation of Liaoning Province

Fundamental Research Funds for the Central Universities

College Students’ Innovative and Entrepreneurial Training Program and Dalian Science and Technology Innovation Fund

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Physical and Theoretical Chemistry,Surfaces and Interfaces,General Medicine,Biotechnology

Reference34 articles.

1. Macrophages are critical effectors of antibody therapies for cancer;Weiskopf;MAbs,2015

2. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation;Solinas;J. Leukoc. Biol.,2009

3. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells;Majeti;Cell,2009

4. CD47 promotes tumor invasion and metastasis in non-small cell lung cancer;Zhao;Sci. Rep.,2016

5. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia;Chao;Cancer Res.,2011

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bismuth selenide nanoparticles enhance radiation sensitivity in colon cancer cells in-vitro;Biochemistry and Biophysics Reports;2024-07

2. Smart nanoparticles for cancer therapy;Signal Transduction and Targeted Therapy;2023-11-03

3. Nanoengineered approaches to improve the efficacy of targeted drug delivery for the treatment of malignancy: a comprehensive review;Future Journal of Pharmaceutical Sciences;2023-10-16

4. Recent advances in functional bismuth chalcogenide nanomaterials: Cancer theranostics, antibacterial and biosensing;Coordination Chemistry Reviews;2023-10

5. Synthesis and Optimization of the Docetaxel-Loaded and Durvalumab-Targeted Human Serum Albumin Nanoparticles, In Vitro Characterization on Triple-Negative Breast Cancer Cells;ACS Omega;2023-07-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3